Manning & Napier Advisors LLC Boosts Position in Sanofi (NASDAQ:SNY)

Manning & Napier Advisors LLC raised its stake in Sanofi (NASDAQ:SNY - Free Report) by 4.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 280,881 shares of the company's stock after purchasing an additional 12,688 shares during the period. Manning & Napier Advisors LLC's holdings in Sanofi were worth $13,547,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Northwest Investment Counselors LLC acquired a new stake in shares of Sanofi in the 3rd quarter valued at about $29,000. Concord Wealth Partners increased its stake in Sanofi by 157.8% in the third quarter. Concord Wealth Partners now owns 593 shares of the company's stock valued at $34,000 after purchasing an additional 363 shares during the period. Fortitude Family Office LLC raised its holdings in shares of Sanofi by 708.6% in the third quarter. Fortitude Family Office LLC now owns 752 shares of the company's stock valued at $43,000 after buying an additional 659 shares during the last quarter. Sunbelt Securities Inc. boosted its stake in shares of Sanofi by 72.1% during the third quarter. Sunbelt Securities Inc. now owns 747 shares of the company's stock worth $43,000 after buying an additional 313 shares during the period. Finally, Versant Capital Management Inc purchased a new position in shares of Sanofi during the fourth quarter worth about $54,000. Institutional investors and hedge funds own 14.04% of the company's stock.

Analysts Set New Price Targets

Separately, StockNews.com downgraded shares of Sanofi from a "buy" rating to a "hold" rating in a research report on Thursday, December 12th.

Sanofi Price Performance

NASDAQ:SNY traded down $0.02 during trading hours on Wednesday, reaching $52.95. 316,594 shares of the company traded hands, compared to its average volume of 2,393,836. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.00 and a quick ratio of 0.65. The firm's 50-day moving average is $48.90 and its 200-day moving average is $52.22. The stock has a market cap of $134.38 billion, a P/E ratio of 27.02, a P/E/G ratio of 1.19 and a beta of 0.57. Sanofi has a 1-year low of $45.22 and a 1-year high of $58.97.

About Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.